Fanconi anemia patients are more susceptible to infection with tumor virus SV40

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Comar, Manola ^a,b   De Rocco, Daniela ^b   Cappelli, Enrico ^c   Zanotta, Nunzia ^a   Bottega, Roberta ^b   Svahn, Johanna ^c   Farruggia, Piero ^d   Misuraca, Aldo ^e   Corsolini, Fabio ^c   Dufour, Carlo ^c   Savoia, Anna ^a,b  

^a INSTITUTE FOR MATERNAL AND CHILD HEALTH IRCCS BURLO GAROFOLO   (Italy)

^b UNIVERSITY OF TRIESTE   (Italy)

^c G GASLINI INSTITUTE   (Italy)

^d ARNAS Civico   (Italy)

^e SANTOBONO PAUSILIPON CHILDREN S HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHILD; CHILD, PRESCHOOL; FANCONI ANEMIA; HUMANS; POLYOMAVIRUS INFECTIONS; RISK FACTORS; SIMIAN VIRUS 40;

EID: 84894196107     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0079683     Document Type: Article

References (43)

1. Crossan GP, Patel KJ (2012) The Fanconi anaemia pathway orchestrates incisions at sites of crosslinked DNA. J Pathol 226: 326-37.
2. Kim H, D'Andrea AD (2012) Regulation of DNA cross-link repair by the Fanconi anemia/BRCA pathway. Genes Dev 26: 1393-408.
3. Tischkowitz MD Hodgson SV (2003) Fanconi anaemia. J Med Genet 40: 1-10. (Pubitemid 36115118)
4. Soulier J (2011) Fanconi anemia. Hematology Am Soc Hematol Educ Program 2011: 492-7.
5. Mathew CG (2006) Fanconi anaemia genes and susceptibility to cancer. Oncogene 25: 5875-84.
6. Shah K, Nathanson N (1976) Human exposure to SV40:review and comment. Am J Epidemiol 103: 1-12.
7. Butel JS (2012) Patterns of polyomavirus SV40 infections and associated cancers in humans: a model. Curr Opin Virol 2: 508-14.
8. Barbanti-Brodano G, Sabbioni S, Martini F, Negrini M, Corallini A, et al. (2004) Simian virus 40 infection in humans and association with human diseases: results and hypotheses. Virology 318: 1-9. (Pubitemid 38234254)
9. Lopez-Rios F, Illei PB, Rusch V, Ladanyi M (2004) Evidence against a role for SV40 infection in human mesotheliomas and high risk of false-positive PCR results owing to presence of SV40 sequences in common laboratory plasmids. Lancet 364: 1157-1166. (Pubitemid 39296603)
10. Lowe DB, Shearer MH, Jumper CA, Kennedy RC (2007) SV40 association with human malignancies and mechanisms of tumor immunity by large tumor antigen. Cell Mol Life Sci 64: 803-14. (Pubitemid 46597754)
11. Lubiniecki AS, Blattner WA, Dosik H, McIntosh S, Wertelecki W (1980) Relationship of SV40 T-antigen expression in vitro to disorders of bone marrow function. Am J Hematol 8: 389-96. (Pubitemid 10090039)
12. Todaro GJ, Green H, Swift MR (1966) Susceptibility of human diploid fibroblast strains to transformation by SV40 virus. Science 153: 1252-4.
13. Dahl J, You J, Benjamin TL (2005) Induction and utilization of an ATM signaling pathway by polyomavirus. J Virol 79: 13007-17. (Pubitemid 41433220)
14. Hein J, Boichuk S, Wu J, Cheng Y, Freire R, et al. (2009) Simian virus 40 large T antigen disrupts genome integrity and activates a DNA damage response via Bub1 binding. J Virol 83: 117-27.
15. Shi Y, Dodson GE, Shaikh S, Rundell K, Tibbetts RS (2005) Ataxia-telangiectasia- mutated (ATM) is a T-antigen kinase that controls SV40 viral replication in vivo. The Journal of biological chemistry 280: 40195-200. (Pubitemid 41779156)
16. Zhao X, Madden-Fuentes RJ, Lou BX, Pipas JM, Gerhardt J, et al. (2008) Ataxia telangiectasia-mutated damage-signaling kinase- and proteasome-dependent destruction of Mre11-Rad50-Nbs1 subunits in Simian virus 40-infected primate cells. J Virol 82: 5316-28. (Pubitemid 351705239)
17. Boichuk S, Hu L, Hein J, Gjoerup OV (2010) Multiple DNA damage signaling and repair pathways deregulated by simian virus 40 large T antigen. J Virol 84: 8007-20.
18. de Araujo MR, Rubira-Bullen IR, Santos CF, Dionisio TJ, Bonfim CM, et al. (2011) High prevalence of oral human papillomavirus infection in Fanconi's anemia patients. Oral Dis 17: 572-6.
19. Hoskins EE, Morreale RJ, Werner SP, Higginbotham JM, Laimins LA, et al. (2012) The Fanconi anemia pathway limits human papillomavirus replication. J Virol 86: 8131-8.
20. Auerbach AD (2009) Fanconi anemia and its diagnosis. Mutat Res 668: 4-10.
21. Malkin D, Chilton-MacNeill S, Meister LA, Sexsmith E, Diller L, et al. (2001) Tissue-specific expression of SV40 in tumors associated with the Li-Fraumeni syndrome. Oncogene 20: 4441-9. (Pubitemid 32772426)
22. Garcea RL, Imperiale MJ (2003) Simian virus 40 infection of humans. J Virol 77: 5039-45. (Pubitemid 36460918)
23. Myers KC, Bleesing JJ, Davies SM, Zhang X, Martin LJ, et al. (2011) Impaired immune function in children with Fanconi anaemia. Br J Haematol 154: 234-40.
24. Digweed M, Demuth I, Rothe S, Scholz R, Jordan A, et al. (2002) SV40 large T-antigen disturbs the formation of nuclear DNA-repair foci containing MRE11. Oncogene 21: 4873-8.
25. Liu JM, Poiley J, Devetten M, Kajigaya S, Walsh CE (1996) The Fanconi anemia complementation group C gene (FAC) suppresses transformation of mutant fibroblasts by the SV40 virus. Biochem Biophys Res Commun 223: 685-90. (Pubitemid 26246134)
26. Comar M, Rizzardi C, de Zotti R, Melato M, Bovenzi M, et al. (2007) SV40 multiple tissue infection and asbestos exposure in a hyperendemic area for malignant mesothelioma. Cancer Res 18: 8456-9. (Pubitemid 47437418)
27. Shah KV (2007) SV40 and human cancer: a review of recent data. Int J Cancer 120: 215-23.
28. Vilchez RA, Butel JS (2003) SV40 in human brain cancers and non-Hodgkin's lymphoma. Oncogene 22: 5164-72. (Pubitemid 37059597)
29. Vilchez RA, Butel JS (2003) Simian virus 40 and its association with human lymphomas. Current oncology reports 5: 372-9. (Pubitemid 38898806)
30. Kean JM, Rao S, Wang M, Garcea RL (2009) Seroepidemiology of human polyomaviruses. PLoS Pathog 5: e1000363.
31. Knowles WA, Pipkin P, Andrews N, Vyse A, Minor P, et al. (2003) Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40. J Med Virol 1: 115-23. (Pubitemid 37121921)
32. Comar M, Zanotta N, Pesel G, Visconti P, Maestri I, et al. (2012) Asbestos and SV40 in malignant pleural mesothelioma from a hyperendemic area of northeastern Italy. Tumori 98: 210-4.
33. Hmeljak J, Kern I, Cor A (2010) No implication of Simian virus 40 in pathogenesis of malignant pleural mesothelioma in Slovenia. Tumori 96: 667-73.
34. Martini F, Corallini A, Balatti V, Sabbioni S, Pancaldi C, et al. (2007) Simian virus 40 in humans. Infect Agent Cancer 2: 13.
35. Mazzoni E, Corallini A, Cristaudo A, Taronna A, Tassi G, et al. (2012) High prevalence of serum antibodies reacting with simian virus 40 capsid protein mimotopes in patients affected by malignant pleural mesothelioma. Proc Natl Acad Sci U S A 44: 18066-71.
36. Cutrone R, Lednicky J, Dunn G, Rizzo P, Bocchetta M, et al. (2005) Some oral poliovirus vaccines were contaminated with infectious SV40 after 1961. Cancer Res 65: 10273-9. (Pubitemid 41743719)
37. Taronna A, Mazzoni E, Corallini A, Bononi I, Pietrobon S, et al. (2013) Serological evidence of an early seroconversion to simian virus 40 in healthy children and adolescents. PloS one 8: e61182.
38. Butel JS (2012) Patterns of polyomavirus SV40 infections and associated cancers in humans: a model. Curr Opin Virol 2: 508-14.
39. Comar M, Zanotta N, Bovenzi M, Campello C (2010) JCV/BKV and SV40 viral load in lymphoid tissues of young immunocompetent children from an area of north-east Italy. J Med Virol 82: 1236-40.
40. Goh S, Lindau C, Tiveljung-Lindell A, Allander T (2009) Merkel cell polyomavirus in respiratory tract secretions. Emerg Infect Dis 15: 489-491.
41. Gheit T, Landi S, Gemignani F, Snijders PJ, Vaccarella S, et al. (2006) Development of a sensitive and specific assay combining multiplex PCR and DNA microarray primer extension to detect high-risk mucosal human papillomavirus types. J Clin Microbiol 44: 2025-31. (Pubitemid 43902148)
42. Polesel J, Gheit T, Talamini R, Shahzad N, Lenardon O, et al. (2012) Urinary human polyomavirus and papillomavirus infection and bladder cancer risk. British journal of cancer 106: 222-6.
43. Schmitt M, Dondog B, Waterboer T, Pawlita M, Tommasino M, et al. (2010) Abundance of multiple high-risk human papillomavirus (HPV) infections found in cervical cells analyzed by use of an ultrasensitive HPV genotyping assay. J Clin Microbiol 48: 143-9.